Results 271 to 280 of about 4,742,503 (345)

Contemporary Surgical Management of Colorectal Cancer in Lynch Syndrome: Considering the Implications of Known Genotype

ANZ Journal of Surgery, EarlyView.
Contemporary surgical management of colorectal cancer in lynch syndrome: considering the implications of known genotype. ABSTRACT Background Lynch syndrome (LS) is an autosomal dominant disorder caused by germline mutations in mismatch repair (MMR) genes, accounting for 1%–3% of all colorectal cancer (CRC) diagnoses.
Ashley Jenkin, Kim‐Chi Phan‐Thien
wiley   +1 more source

The expression and relationship of VEGF and MVD in type I endometrial cancer. [PDF]

Medicine (Baltimore)
Bai S, Wu Q, Song L.
europepmc   +1 more source

Long‐term outcomes of fertility‐sparing treatment in endometrial carcinoma and endometrial intraepithelial neoplasia: Recurrence risk factors over a 9‐year follow‐up

Acta Obstetricia et Gynecologica Scandinavica, EarlyView.
Fertility‐sparing treatment demonstrated a 62.5% recurrence rate at 10 years. Recurrence was more likely in patients initially treated with megestrol acetate or those with a family history of cancer. As most patients lacked high‐risk molecular features, conservative treatment may remain a safe option for selected individuals under close long‐term ...
Ya‐Ting Hsu, Heng‐Cheng Hsu, Chia‐Yi Lee, Wan‐Ting Hung, Chi‐Hau Chen   +4 more
wiley   +1 more source

Mark3 a Prognostic Marker for the Endometrial Cancer. [PDF]

Curr Oncol
Wang Y, Guo L.
europepmc   +1 more source

A characteristic gene expression profile regulated by ACIN1::NUTM1 fusion in a newly identified infant leukaemic cell line and an ACIN1::NUTM1‐inducible model

British Journal of Haematology, EarlyView.
An ACIN1::NUTM1‐positive ALL cell line, KOPN32, which was previously established from a relapsed infant‐ALL case, was newly identified. Comparison using 94 BCP‐ALL cell lines, an ACIN1::NUTM1‐inducible ALL model and clinical sample data revealed upregulation of HOXA9, HOXA10, SKIDA1 and BMI1, indicating direct involvement of ACIN1::NUTM1 fusion in the ...
Minori Tamai, Chiaki Komatsu, Keiko Kagami, Shin Kasai, Atsushi Watanabe, Koshi Akahane, Kumiko Goi, Chihiro Tomoyasu, Toshihiko Imamura, Satoshi Oguri, Sumio Iwasaki, Takanori Teshima, Yasushi Yatabe, Takeshi Inukai   +13 more
wiley   +1 more source

LncRNA MALAT1 as a prognostic biomarker in endometrial cancer: a molecular genetics approach. [PDF]

Discov Oncol
Liu X, Xiao J, Ma J.
europepmc   +1 more source

A study of oral metformin for the intravesical treatment of non‐muscle‐invasive bladder cancer

BJU International, EarlyView.
Objectives To evaluate the effect of metformin on non‐muscle‐invasive bladder cancer (NMIBC) marker lesions. Patients and methods A phase II, open‐label, multicentre, marker lesion trial using oral metformin in patients with primary or recurrent, multiple, low‐grade Ta‐T1 NMIBC was conducted. After transurethral resection for histological confirmation,
Jons W. van Hattum, Marinka J. Remmelink, Sieb T. Nuijens, Ben Max de Ruiter, Gerrit K.J. Hooijer, Jorg R. Oddens, C. Dilara Savci‐Heijink, Ron Mathot, J. Alfred Witjes, Michael .N. Pollak, Theo M. de Reijke, Remco J. Molenaar, Hanneke W. Wilmink   +12 more
wiley   +1 more source

False detection and the value of combined tracer mapping in endometrial cancer: a dual case presentation. [PDF]

J Surg Case Rep
Szatkowski W, Pniewska K, Blecharz P.
europepmc   +1 more source